Skip to content

Clinical trials

Phase 2/3 Macular Edema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Edema Phase: Phase 2/3 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20122
20192
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3
Completed2
Withdrawn2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Benha University1
Imperial College London1
Isfahan Ophthalmology Research Center1
Isfahan University of Medical Sciences1
Johns Hopkins University1
Peking Union Medical College Hospital1
Retina Specialists, PC1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Edema9
Diabetic Retinopathy3
Central Serous Chorioretinopathy1
Diabetes Mellitus1
Diabetes Mellitus, Type 11
Diabetes Mellitus, Type 21
Epiretinal Membrane1
Papilledema1
Pars Planitis1
Retinal Neovascularization1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.